Frank Osterkamp
Impact in
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research
Papers in
- Oncology 11
- Peptidase Inhibition and Analysis 9
-
- Radiopharmaceutical Chemistry and Applications 7
- Co-authors
- Christiane Smerling (9 shared papers)Ulrich Reineke (9 shared papers)Richard P. Baum (5 shared papers)Aileen Hoehne (8 shared papers)Harshad Kulkarni (4 shared papers)Christiane Schuchardt (4 shared papers)Aviral Singh (3 shared papers)Dirk Zboralski (7 shared papers)
- Journals
- Journal of Nuclear Medicine (5 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)iScience (1 paper)Molecular Cancer Therapeutics (1 paper)Chemical Communications (1 paper)
- Partner nations
- GermanyUnited StatesThailand
In The Last Decade
Frank Osterkamp
21 papers receiving 578 citations
Frank Osterkamp's Hit Papers
Peers
Comparison fields: 5 of 56
- Oncology 361
- Immunology and Allergy 64
- Radiology, Nuclear Medicine and Imaging 214
- Cellular and Molecular Neuroscience 124
- Cancer Research 92
Countries citing papers authored by Frank Osterkamp
This map shows the geographic impact of Frank Osterkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Osterkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Osterkamp more than expected).
Fields of papers citing papers by Frank Osterkamp
This network shows the impact of papers produced by Frank Osterkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Osterkamp. The network helps show where Frank Osterkamp may publish in the future.
Co-authors
The 25 scholars most cited alongside Frank Osterkamp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results Hit paper breakdown → | 2021 | 210 |
| 2 | 2017 | 58 | |
| 3 | 2007 | 57 | |
| 4 | 2017 | 40 | |
| 5 | 2016 | 30 | |
| 6 | 2023 | 27 | |
| 7 | 2004 | 26 | |
| 8 | 2000 | 25 | |
| 9 | 1999 | 20 | |
| 10 | 2024 | 16 | |
| 11 | 2020 | 14 | |
| 12 | 1999 | 13 | |
| 13 | 2023 | 11 | |
| 14 | 2001 | 10 | |
| 15 | 2009 | 6 | |
| 16 | 2009 | 5 | |
| 17 | 2022 | 4 | |
| 18 | Peptide-Targeted Radionuclide Therapy (PTRT) using Lu-177 FAP-2286 in Diverse Adenocarcinomas: Feasibility, Biodistribution and Preliminary Dosimetry in a First-in-human study | 2020 | 4 |
| 19 | 2021 | 4 | |
| 20 | Radiopeptide Therapy using Lu-177 3BP-227 in a Patient with Pancreatic Adenocarcinoma | 2015 | 2 |
About Frank Osterkamp
Frank Osterkamp is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Cellular and Molecular Neuroscience, Molecular Biology and Epidemiology, having authored 21 papers that have together received 584 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (9 papers), Neuropeptides and Animal Physiology (7 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Cell Adhesion Molecules Research (5 papers), Neuroendocrine Tumor Research Advances (5 papers), Platelet Disorders and Treatments (3 papers), Carbohydrate Chemistry and Synthesis (2 papers) and Protease and Inhibitor Mechanisms (2 papers). The work is most often cited by research in Oncology (361 citations), Immunology and Allergy (64 citations), Radiology, Nuclear Medicine and Imaging (214 citations), Cellular and Molecular Neuroscience (124 citations) and Cancer Research (92 citations). Frank Osterkamp has collaborated with scholars based in Germany, United States and Thailand. Frequent co-authors include Christiane Smerling, Ulrich Reineke, Richard P. Baum, Aileen Hoehne, Harshad Kulkarni, Christiane Schuchardt, Aviral Singh, Dirk Zboralski, Jingjing Zhang and Dirk Müeller. Their work appears in journals such as Journal of Nuclear Medicine, Bioorganic & Medicinal Chemistry Letters, iScience, Molecular Cancer Therapeutics and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.